Pain Management

Researchers evaluated the safety, feasibility, and effectiveness of intranasal fentanyl in an adult population.

Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.

Madison Irwin, PharmD, BCPS, discusses her career pharmacy and how she thinks high rates of chronic pain will impact the field in the coming years.

The calcitonin gene-related peptide monoclonal antibody significantly reduced the number of monthly migraine days.

No medications were associated with improved quality of life or reduced headache duration.

ATX101 from Allay Therapeutics is designed for use following total knee arthroplasty in adults and has shown positive results in multiple studies.

Pain, fatigue, and sleep disturbances are common symptoms with rheumatic diseases.

AMA released its 2024 Overdose Epidemic Report and presented key findings from the past year.

Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.

Catch up on important nonopioid pain management news from November 2024.

A number of new, nonopioid osteoarthritis treatment options are either available for patients or in the development pipeline.

PROMIS scores demonstrated the disparities between reported pain and mental health outcomes.

NSAIDS are typically the first line of treatment for axial spondyloarthritis.

Chronic pain is more prevalent—and more severe—in veterans compared with the general US population.

Investigators evaluated the role that cannabis plays in pain management in different populations with rheumatic diseases.

The Mediterranean diet is largely considered one of the healthiest diets.

Researchers aimed to determine the frequency of pain assessments and the extent of pain scores by age for patients undergoing traumatic surgery.

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

Melissa Durham, PharmD, MACM, reveals how pharmacists are uniquely positioned to counsel patients on nonopioid pain management.

The FDA has mandated that companies participating in the Opioid Analgesic Risk Evaluation and Mitigation Strategy program provide pre-paid mail-back envelopes for unused or expired opioid medications.

The addition of a 10 mg oxycodone hydrochloride tablet improves dosing flexibility and precision.

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

The 70-plus-page lawsuit is directed at Express Scripts for its dealings with drug manufacturers in fueling the US opioid crisis.

Whether patients present with complaints of an aching muscle from a workout or a sudden twinge in the back, consider recommending these topical analgesics.

Although there has recently been an effort to improve pediatric pain treatment, it is still often underestimated and not adequately managed.